Alyeska Investment Group, L.P. Eye Point Pharmaceuticals, Inc. Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 351,348 shares of EYPT stock, worth $3.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
351,348
Previous 351,348
-0.0%
Holding current value
$3.19 Million
Previous $2.62 Million
27.24%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
71.6MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$75.7 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$61.8 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$56.4 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$37.7 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$37.1 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $310M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...